These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 14714440)

  • 41. Flavivirus infection-A review of immunopathogenesis, immunological response, and immunodiagnosis.
    Chong HY; Leow CY; Abdul Majeed AB; Leow CH
    Virus Res; 2019 Dec; 274():197770. PubMed ID: 31626874
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dengue and other emerging flaviviruses.
    Solomon T; Mallewa M
    J Infect; 2001 Feb; 42(2):104-15. PubMed ID: 11531316
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-throughput neutralization assay for multiple flaviviruses based on single-round infectious particles using dengue virus type 1 reporter replicon.
    Matsuda M; Yamanaka A; Yato K; Yoshii K; Watashi K; Aizaki H; Konishi E; Takasaki T; Kato T; Muramatsu M; Wakita T; Suzuki R
    Sci Rep; 2018 Nov; 8(1):16624. PubMed ID: 30413742
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Review on flavivirus vaccine development. Proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26-27 April 2004, Bangkok, Thailand.
    Hombach J; Barrett AD; Cardosa MJ; Deubel V; Guzman M; Kurane I; Roehrig JT; Sabchareon A; Kieny MP
    Vaccine; 2005 Apr; 23(21):2689-95. PubMed ID: 15841565
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acute West Nile virus neuroinvasive infections: cross-reactivity with dengue virus and tick-borne encephalitis virus.
    Papa A; Karabaxoglou D; Kansouzidou A
    J Med Virol; 2011 Oct; 83(10):1861-5. PubMed ID: 21837806
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New developments in flavivirus vaccines with special attention to yellow fever.
    Pugachev KV; Guirakhoo F; Monath TP
    Curr Opin Infect Dis; 2005 Oct; 18(5):387-94. PubMed ID: 16148524
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Many Faces of a Dynamic Virion: Implications of Viral Breathing on Flavivirus Biology and Immunogenicity.
    Dowd KA; Pierson TC
    Annu Rev Virol; 2018 Sep; 5(1):185-207. PubMed ID: 30265634
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Short report: absence of protective neutralizng antibodies to West Nile virus in subjects following vaccination with Japanese encephalitis or dengue vaccines.
    Kanesa-Thasan N; Putnak JR; Mangiafico JA; Saluzzo JE; Ludwig GV
    Am J Trop Med Hyg; 2002 Feb; 66(2):115-6. PubMed ID: 12135278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular amplification assays for the detection of flaviviruses.
    Lanciotti RS
    Adv Virus Res; 2003; 61():67-99. PubMed ID: 14714430
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sequence of the genes encoding the structural proteins of the low-virulence tick-borne flaviviruses Langat TP21 and Yelantsev.
    Mandl CW; Iacono-Connors L; Wallner G; Holzmann H; Kunz C; Heinz FX
    Virology; 1991 Dec; 185(2):891-5. PubMed ID: 1720591
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Genome sequence and antigen structure of the Powassan virus: analysis of genetic elements of tick-transmitted flaviviruses].
    Mandl C
    Wien Klin Wochenschr; 1995; 107(3):101-2. PubMed ID: 7886964
    [No Abstract]   [Full Text] [Related]  

  • 52. Noncoding Subgenomic Flavivirus RNA Is Processed by the Mosquito RNA Interference Machinery and Determines West Nile Virus Transmission by Culex pipiens Mosquitoes.
    Göertz GP; Fros JJ; Miesen P; Vogels CBF; van der Bent ML; Geertsema C; Koenraadt CJM; van Rij RP; van Oers MM; Pijlman GP
    J Virol; 2016 Nov; 90(22):10145-10159. PubMed ID: 27581979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA-based control of tick-borne flavivirus neuropathogenesis: Challenges and perspectives.
    Teterina NL; Maximova OA; Kenney H; Liu G; Pletnev AG
    Antiviral Res; 2016 Mar; 127():57-67. PubMed ID: 26794396
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Production and Biomedical Application of Flavivirus-like Particles.
    Krol E; Brzuska G; Szewczyk B
    Trends Biotechnol; 2019 Nov; 37(11):1202-1216. PubMed ID: 31003718
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lipids and flaviviruses, present and future perspectives for the control of dengue, Zika, and West Nile viruses.
    Martín-Acebes MA; Vázquez-Calvo Á; Saiz JC
    Prog Lipid Res; 2016 Oct; 64():123-137. PubMed ID: 27702593
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic vaccination of mice with plasmids encoding the NS1 non-structural protein from tick-borne encephalitis virus and dengue 2 virus.
    Timofeev AV; Butenko VM; Stephenson JR
    Virus Genes; 2004 Jan; 28(1):85-97. PubMed ID: 14739654
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tick-borne flaviviruses.
    Gritsun TS; Nuttall PA; Gould EA
    Adv Virus Res; 2003; 61():317-71. PubMed ID: 14714436
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chimeric dengue 2 PDK-53/West Nile NY99 viruses retain the phenotypic attenuation markers of the candidate PDK-53 vaccine virus and protect mice against lethal challenge with West Nile virus.
    Huang CY; Silengo SJ; Whiteman MC; Kinney RM
    J Virol; 2005 Jun; 79(12):7300-10. PubMed ID: 15919884
    [TBL] [Abstract][Full Text] [Related]  

  • 59. T lymphocyte responses to flaviviruses - diverse cell populations affect tendency toward protection and disease.
    Sanchez Vargas LA; Mathew A; Rothman AL
    Curr Opin Virol; 2020 Aug; 43():28-34. PubMed ID: 32810785
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection.
    Pierson TC; Diamond MS
    Expert Rev Mol Med; 2008 May; 10():e12. PubMed ID: 18471342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.